Pharmaceutical Protections in U.S. Trade Deals - What Do Americans Get in Return?

N Engl J Med. 2019 May 23;380(21):1993-1995. doi: 10.1056/NEJMp1902240. Epub 2019 May 1.

Authors

Thomas Bollyky¹, Aaron S Kesselheim¹

Affiliation

¹ From the Council on Foreign Relations, Washington, DC (T.B.); and the Program on Regulation, Therapeutics, and Law (PORTAL), Department of Medicine, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston (A.S.K.).

PMID: 31042823
DOI: 10.1056/NEJMp1902240

No abstract available

MeSH terms

Biological Products
Commerce / legislation & jurisprudence*
Drug Industry / economics
Drug Industry / legislation & jurisprudence*
International Cooperation*
Legislation, Drug*
Ownership / legislation & jurisprudence
United States

Substances

Biological Products